Clinical trial
An Open Label Phase 1 Trial of Losartan for Worsening Respiratory Illness in COVID-19
NCT04335123 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Phase 1 Trial of Losartan for Worsening Respiratory Illness in COVID-19
- Lead sponsor
- University of Kansas Medical Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 4, 2020
- Completion date
- August 17, 2020
- Enrollment
- 34 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.